Effect of turosteride, a 5α-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma
- 1 February 1997
- journal article
- Published by Wiley in The Prostate
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Endocrine properties of the testosterone 5α-reductase inhibitor turosteride (FCE 26073)The Journal of Steroid Biochemistry and Molecular Biology, 1994
- Hormonal effects of turosteride, a 5α-reductase inhibitor, in the ratThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Systemic therapy of prostate cancer. new concepts from prostate cancer tumor biologyCancer Treatment Reviews, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- 17β-acylurea derivatives of 4-azasteroids as inhibitors of testosterone 5α-reductaseThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Response of rat and human prostatic cancers to the novel 5α‐reductase inhibitor, SK&F 105657The Prostate, 1992
- Effect of castration, DES, flutamide, and the 5α-reductase inhibitor, MK-906, on the growth of the dunning rat prostatic carcinoma, R-3327The Prostate, 1991
- The clinical development of a 5α-reductase inhibitor, finasterideThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Kinetic Parameters of 5α-Reductase Activity in Stroma and Epithelium of Normal, Hyperplastic, and Carcinomatous Human Prostates*Journal of Clinical Endocrinology & Metabolism, 1988
- 5α-Reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the ratSteroids, 1986